May 2026 Sanstar Limited entered into a strategic partnership and joint venture with Ingredion Incorporated to expand specialty pharmaceutical excipient manufacturing in India, strengthening the supply of high-value ingredients, including tablet formulation excipients such as magnesium stearate.
May 2026 Safic-Alcan acquired a majority stake in S.A. Ingredients Pvt. Ltd., expanding its life sciences distribution network in India and enhancing access to pharmaceutical excipients, including magnesium stearate, for regional manufacturers.
October 2025 Peter Greven expanded its pharmaceutical excipient portfolio by strengthening production and quality capabilities for pharmaceutical-grade metallic stearates, including magnesium stearate, to meet increasing global demand.
August 2025 Baerlocher expanded production of specialty metallic stearates at its global manufacturing facilities to support growing demand from the pharmaceutical, food, and personal care industries.
June 2025 Valtris Specialty Chemicals enhanced its metallic stearates product portfolio through continued investments in manufacturing and technical support, strengthening the supply of high-purity magnesium stearate for pharmaceutical and industrial applications.